Listed

ImageneBio, Inc.

IMANasdaqCIK 1835579HealthcareFiscal year ends Dec 31

Share

Share this page

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last eight fiscal years. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$800.0k, FY2025
Operating income−$48.5m, FY2025
Net income−$45.3m, FY2025
Line itemUnitFY2020-12-31FY20212021-12-31FY20222022-12-31FY20232023-12-31FY20242024-12-31FY20252025-12-31
Revenue$m9.2Revenue, period not labelled, twelve months to 2020-12-31$9.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2022-03-17, accession 0000950170-22-003998.Report this figure31.0Revenue, FY2021, twelve months to 2021-12-31$31.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2023-03-14, accession 0000950170-23-007681.Report this figure15.6Revenue, FY2022, twelve months to 2022-12-31$15.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-03-12, accession 0000950170-24-029651.Report this figure9.2Revenue, FY2023, twelve months to 2023-12-31$9.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-06, accession 0000950170-25-034188.Report this figure3.5Revenue, FY2024, twelve months to 2024-12-31$3.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-10, accession 0001193125-26-099434.Report this figure0.8Revenue, FY2025, twelve months to 2025-12-31$800.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-10, accession 0001193125-26-099434.Report this figure
Research and development$m44.8Research and development, period not labelled, twelve months to 2020-12-31$44.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2022-03-17, accession 0000950170-22-003998.Report this figure47.1Research and development, FY2021, twelve months to 2021-12-31$47.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2023-03-14, accession 0000950170-23-007681.Report this figure64.3Research and development, FY2022, twelve months to 2022-12-31$64.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2024-03-12, accession 0000950170-24-029651.Report this figure59.7Research and development, FY2023, twelve months to 2023-12-31$59.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-06, accession 0000950170-25-034188.Report this figure32.1Research and development, FY2024, twelve months to 2024-12-31$32.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-10, accession 0001193125-26-099434.Report this figure28.5Research and development, FY2025, twelve months to 2025-12-31$28.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-10, accession 0001193125-26-099434.Report this figure
Operating income$m(44.5)Operating income, period not labelled, twelve months to 2020-12-31−$44.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2022-03-17, accession 0000950170-22-003998.Report this figure(34.1)Operating income, FY2021, twelve months to 2021-12-31−$34.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2023-03-14, accession 0000950170-23-007681.Report this figure(70.9)Operating income, FY2022, twelve months to 2022-12-31−$70.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2024-03-12, accession 0000950170-24-029651.Report this figure(75.4)Operating income, FY2023, twelve months to 2023-12-31−$75.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-06, accession 0000950170-25-034188.Report this figure(37.0)Operating income, FY2024, twelve months to 2024-12-31−$37.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-10, accession 0001193125-26-099434.Report this figure(48.5)Operating income, FY2025, twelve months to 2025-12-31−$48.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-10, accession 0001193125-26-099434.Report this figure
Income tax$mnot reported0.0Income tax, FY2021, twelve months to 2021-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2022-03-17, accession 0000950170-22-003998.Report this figure0.0Income tax, FY2022, twelve months to 2022-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2023-03-14, accession 0000950170-23-007681.Report this figure(0.2)Income tax, FY2023, twelve months to 2023-12-31−$162.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2025-03-06, accession 0000950170-25-034188.Report this figure0.0Income tax, FY2024, twelve months to 2024-12-31$13.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-10, accession 0001193125-26-099434.Report this figure(0.4)Income tax, FY2025, twelve months to 2025-12-31−$350.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-10, accession 0001193125-26-099434.Report this figure
Net income$m(44.3)Net income, period not labelled, twelve months to 2020-12-31−$44.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2022-03-17, accession 0000950170-22-003998.Report this figure(34.1)Net income, FY2021, twelve months to 2021-12-31−$34.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2023-03-14, accession 0000950170-23-007681.Report this figure(68.8)Net income, FY2022, twelve months to 2022-12-31−$68.8m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2024-03-12, accession 0000950170-24-029651.Report this figure(68.2)Net income, FY2023, twelve months to 2023-12-31−$68.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-06, accession 0000950170-25-034188.Report this figure(36.6)Net income, FY2024, twelve months to 2024-12-31−$36.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-10, accession 0001193125-26-099434.Report this figure(45.3)Net income, FY2025, twelve months to 2025-12-31−$45.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-10, accession 0001193125-26-099434.Report this figure
Diluted EPS$ per share(16.00)Diluted EPS, period not labelled, twelve months to 2020-12-31−$16.00 per share. XBRL concept us-gaap:EarningsPerShareBasicAndDiluted. 10-K filed 2022-03-17, accession 0000950170-22-003998.Report this figure(1.22)Diluted EPS, FY2021, twelve months to 2021-12-31−$1.22 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2023-03-14, accession 0000950170-23-007681.Report this figure(1.90)Diluted EPS, FY2022, twelve months to 2022-12-31−$1.90 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2024-03-12, accession 0000950170-24-029651.Report this figure(1.63)Diluted EPS, FY2023, twelve months to 2023-12-31−$1.63 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2025-03-06, accession 0000950170-25-034188.Report this figure(22.10)Diluted EPS, FY2024, twelve months to 2024-12-31−$22.10 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-03-10, accession 0001193125-26-099434.Report this figure(9.64)Diluted EPS, FY2025, twelve months to 2025-12-31−$9.64 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-03-10, accession 0001193125-26-099434.Report this figure
Basic EPS$ per sharenot reported(1.22)Basic EPS, FY2021, twelve months to 2021-12-31−$1.22 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-K filed 2023-03-14, accession 0000950170-23-007681.Report this figure(1.90)Basic EPS, FY2022, twelve months to 2022-12-31−$1.90 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-K filed 2024-03-12, accession 0000950170-24-029651.Report this figure(1.63)Basic EPS, FY2023, twelve months to 2023-12-31−$1.63 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-K filed 2025-03-06, accession 0000950170-25-034188.Report this figure(22.10)Basic EPS, FY2024, twelve months to 2024-12-31−$22.10 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-K filed 2026-03-10, accession 0001193125-26-099434.Report this figure(9.64)Basic EPS, FY2025, twelve months to 2025-12-31−$9.64 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-K filed 2026-03-10, accession 0001193125-26-099434.Report this figure

Balance sheet

Cash and equivalents$94.5m, FY2025
Shareholders' equity$133.1m, FY2025
Line itemUnitFY20212021-12-31FY20222022-12-31FY20232023-12-31FY20242024-12-31FY20252025-12-31
Cash and equivalents$m232Cash and equivalents, FY2021, at 2021-12-31$232.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2023-03-14, accession 0000950170-23-007681.Report this figure59.9Cash and equivalents, FY2022, at 2022-12-31$59.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2024-03-12, accession 0000950170-24-029651.Report this figure120Cash and equivalents, FY2023, at 2023-12-31$119.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-06, accession 0000950170-25-034188.Report this figure12.1Cash and equivalents, FY2024, at 2024-12-31$12.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-10, accession 0001193125-26-099434.Report this figure94.5Cash and equivalents, FY2025, at 2025-12-31$94.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-05, accession 0001193125-26-333920.Report this figure
Current assets$m237Current assets, FY2021, at 2021-12-31$236.5m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2023-03-14, accession 0000950170-23-007681.Report this figure160Current assets, FY2022, at 2022-12-31$160.0m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2024-03-12, accession 0000950170-24-029651.Report this figure179Current assets, FY2023, at 2023-12-31$178.7m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-06, accession 0000950170-25-034188.Report this figure12.5Current assets, FY2024, at 2024-12-31$12.5m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-10, accession 0001193125-26-099434.Report this figure140Current assets, FY2025, at 2025-12-31$140.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-05, accession 0001193125-26-333920.Report this figure
Total assets$m248Total assets, FY2021, at 2021-12-31$247.9m. XBRL concept us-gaap:Assets. 10-K filed 2023-03-14, accession 0000950170-23-007681.Report this figure172Total assets, FY2022, at 2022-12-31$172.3m. XBRL concept us-gaap:Assets. 10-K filed 2024-03-12, accession 0000950170-24-029651.Report this figure192Total assets, FY2023, at 2023-12-31$192.1m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-06, accession 0000950170-25-034188.Report this figure15.9Total assets, FY2024, at 2024-12-31$15.9m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-10, accession 0001193125-26-099434.Report this figure153Total assets, FY2025, at 2025-12-31$153.0m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-05, accession 0001193125-26-333920.Report this figure
Current liabilities$m27.2Current liabilities, FY2021, at 2021-12-31$27.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2023-03-14, accession 0000950170-23-007681.Report this figure21.5Current liabilities, FY2022, at 2022-12-31$21.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2024-03-12, accession 0000950170-24-029651.Report this figure14.2Current liabilities, FY2023, at 2023-12-31$14.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-06, accession 0000950170-25-034188.Report this figure17.2Current liabilities, FY2024, at 2024-12-31$17.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-10, accession 0001193125-26-099434.Report this figure11.2Current liabilities, FY2025, at 2025-12-31$11.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-05, accession 0001193125-26-333920.Report this figure
Total liabilities$m40.0Total liabilities, FY2021, at 2021-12-31$40.0m. XBRL concept us-gaap:Liabilities. 10-K filed 2023-03-14, accession 0000950170-23-007681.Report this figure25.3Total liabilities, FY2022, at 2022-12-31$25.3m. XBRL concept us-gaap:Liabilities. 10-K filed 2024-03-12, accession 0000950170-24-029651.Report this figure22.3Total liabilities, FY2023, at 2023-12-31$22.3m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-06, accession 0000950170-25-034188.Report this figure17.4Total liabilities, FY2024, at 2024-12-31$17.4m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-10, accession 0001193125-26-099434.Report this figure19.8Total liabilities, FY2025, at 2025-12-31$19.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-05, accession 0001193125-26-333920.Report this figure
Current portion of debt$mnot reportednot reportednot reported7.5Current portion of debt, FY2024, at 2024-12-31$7.5m. XBRL concept us-gaap:DebtCurrent. 10-K filed 2026-03-10, accession 0001193125-26-099434.Report this figure0.0Current portion of debt, FY2025, at 2025-12-31$0. XBRL concept us-gaap:DebtCurrent. 10-K filed 2026-03-10, accession 0001193125-26-099434.Report this figure
Shareholders' equity$m208Shareholders' equity, FY2021, at 2021-12-31$207.9m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2024-03-12, accession 0000950170-24-029651.Report this figure147Shareholders' equity, FY2022, at 2022-12-31$147.0m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2025-03-06, accession 0000950170-25-034188.Report this figure(126)Shareholders' equity, FY2023, at 2023-12-31−$126.1m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-10, accession 0001193125-26-099434.Report this figure(161)Shareholders' equity, FY2024, at 2024-12-31−$160.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001193125-26-333920.Report this figure133Shareholders' equity, FY2025, at 2025-12-31$133.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001193125-26-333920.Report this figure

Cash flow

Operating cash flow−$47.8m, FY2025
Capital expenditure$414.0k, FY2023
Share repurchases$663.0k, FY2023
Line itemUnitFY2020-12-31FY20212021-12-31FY20222022-12-31FY20232023-12-31FY20242024-12-31FY20252025-12-31
Operating cash flow$m(37.8)Operating cash flow, period not labelled, twelve months to 2020-12-31−$37.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2022-03-17, accession 0000950170-22-003998.Report this figure(60.3)Operating cash flow, FY2021, twelve months to 2021-12-31−$60.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2023-03-14, accession 0000950170-23-007681.Report this figure(74.1)Operating cash flow, FY2022, twelve months to 2022-12-31−$74.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2024-03-12, accession 0000950170-24-029651.Report this figure(79.7)Operating cash flow, FY2023, twelve months to 2023-12-31−$79.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-06, accession 0000950170-25-034188.Report this figure(21.3)Operating cash flow, FY2024, twelve months to 2024-12-31−$21.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-10, accession 0001193125-26-099434.Report this figure(47.8)Operating cash flow, FY2025, twelve months to 2025-12-31−$47.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-10, accession 0001193125-26-099434.Report this figure
Capital expenditure$m0.8Capital expenditure, period not labelled, twelve months to 2020-12-31$766.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2022-03-17, accession 0000950170-22-003998.Report this figure1.8Capital expenditure, FY2021, twelve months to 2021-12-31$1.8m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2023-03-14, accession 0000950170-23-007681.Report this figure1.4Capital expenditure, FY2022, twelve months to 2022-12-31$1.4m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2024-03-12, accession 0000950170-24-029651.Report this figure0.4Capital expenditure, FY2023, twelve months to 2023-12-31$414.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-06, accession 0000950170-25-034188.Report this figurenot reportednot reported
Share repurchases$mnot reportednot reportednot reported0.7Share repurchases, FY2023, twelve months to 2023-12-31$663.0k. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2025-03-06, accession 0000950170-25-034188.Report this figurenot reportednot reported

Shares

Diluted shares (weighted)48.26m, FY2024
Line itemUnitFY20212021-12-31FY20222022-12-31FY20232023-12-31FY20242024-12-31
Diluted shares (weighted)m shares28.0Diluted shares (weighted), FY2021, twelve months to 2021-12-3127,983,359 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-K filed 2023-03-14, accession 0000950170-23-007681.Report this figure36.2Diluted shares (weighted), FY2022, twelve months to 2022-12-3136,188,420 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-K filed 2024-03-12, accession 0000950170-24-029651.Report this figure41.7Diluted shares (weighted), FY2023, twelve months to 2023-12-3141,735,081 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-K filed 2025-03-06, accession 0000950170-25-034188.Report this figure48.3Diluted shares (weighted), FY2024, twelve months to 2024-12-3148,258,111 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-K filed 2025-03-06, accession 0000950170-25-034188.Report this figure

Shares outstanding: 11.35mShares outstanding, period not labelled, at 2026-07-3111,351,456 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-05, accession 0001193125-26-333920.Report this figure at Jul 31, 2026, from the cover of the 10-Q filed Aug 5, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. Listed shows no prices and gives no investment advice.